Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Metabolic Bone Disease (Find 6 items)

Sort Metabolic Bone Disease Alphabetically

Metabolic Bone Disease

Explore a range of Metabolic Bone Disease Pharma Intermediates for pharmaceutical research and production. Access raw materials with detailed CAS numbers, property data, and SDS to support the development of drugs for osteoporosis, rickets, Paget’s disease, and other bone metabolism disorders. Source high-quality intermediates from certified suppliers for reliable and safe usage.

Product List

Request for quotation , get quotes from more suppliers.

3-Pyridineacetic acid, hydrochloride (1:1)

(6419-36-9)
3-Pyridylacetic Acid is a metabolite of Nicotine (N412420). 3-Pyridylacetic Acid is an antilipemic.

Product List

Request for quotation , get quotes from more suppliers.

3-Pyridineacetic acid

(501-81-5)
3-Pyridineacetic acid is a higher homologue of nicotinic acid, a breakdown product of nicotine (and other tobacco alkaloids).

Product List

Request for quotation , get quotes from more suppliers.

N-(5-Chloro-2-pyridyl)triflimide

(145100-51-2)
It is used to produce vinyl trifluoromethanesulfonate with high yield from the corresponding ketoenolate or dienolate.

Product List

Request for quotation , get quotes from more suppliers.

11085-36-2

(11085-36-2)

Request for quotation , get quotes from more suppliers.

Metabolic Bone Disease drug intermediates are some key chemical raw materials or products in the synthesis process of metabolic bone disease drugs. You can easily find high-quality new intermediates, products and their manufacturers or suppliers on ECHEMI. We will always track the research and development of new products on metabolic bone disease.

More Information

Metabolic Bone Disease Pharma Intermediates are essential raw materials used in the synthesis of therapeutics targeting bone metabolism disorders. These intermediates provide the foundation for osteoporosis treatments, vitamin D analogues, calcium regulators, and bone resorption modulators.

Common applications and types include:
• Vitamin D and analog intermediates — for promoting bone mineralization and treating rickets or osteomalacia.
• Calcium and phosphate regulators — supporting drugs that maintain proper mineral balance.
• Bisphosphonate intermediates — used to inhibit bone resorption in osteoporosis and Paget’s disease.
• Parathyroid hormone (PTH) intermediates — for managing calcium homeostasis and bone formation.

Frequently Asked Questions

What is Metabolic Bone Disease?

Metabolic Bone Disease (MBD) refers to a group of disorders characterized by abnormalities in bone strength, structure, or mineralization due to disturbances in calcium, phosphorus, vitamin D metabolism, or hormonal regulation. Common types include osteoporosis, osteomalacia, rickets, and Paget’s disease. These conditions can lead to increased fracture risk, bone pain, and skeletal deformities if left untreated.

What are the common causes of Metabolic Bone Disease?

Common causes of Metabolic Bone Disease include vitamin D deficiency, inadequate calcium intake, chronic kidney disease, hyperparathyroidism, hormonal imbalances (such as low estrogen or testosterone), and certain medications like glucocorticoids. Lifestyle factors such as sedentary behavior, smoking, and excessive alcohol consumption can also contribute to the development of MBD.

How is Metabolic Bone Disease diagnosed?

Diagnosis of Metabolic Bone Disease typically involves a combination of clinical evaluation, blood tests (to assess calcium, phosphorus, alkaline phosphatase, vitamin D, and parathyroid hormone levels), imaging studies like dual-energy X-ray absorptiometry (DXA) scans for bone mineral density, and sometimes bone biopsies. Early diagnosis is crucial to prevent complications such as fractures and progressive bone loss.

What are the treatment options for Metabolic Bone Disease?

Treatment for Metabolic Bone Disease depends on the underlying cause but often includes nutritional supplementation (e.g., calcium and vitamin D), lifestyle modifications (weight-bearing exercise, smoking cessation), and medications such as bisphosphonates, denosumab, teriparatide, or hormone replacement therapy. In cases related to kidney disease or endocrine disorders, managing the primary condition is essential for effective bone health restoration.

Can Metabolic Bone Disease be prevented?

Yes, many forms of Metabolic Bone Disease can be prevented through adequate intake of calcium and vitamin D, regular weight-bearing physical activity, avoiding tobacco and excessive alcohol, and routine bone density screening—especially for high-risk groups such as postmenopausal women and older adults. Early intervention and management of underlying medical conditions also play a key role in prevention.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.